Biomarkers in advanced prostate cancer: Liquid biopsy, ctDNA, and more
February 10th 2025"The management of advanced prostate cancer has evolved significantly, driven in part by the integration of diverse biomarkers that guide treatment decisions from diagnosis through progression," says Nedim Ruhotina, MD.